Published on

Medicine – Eosinophilia

Eosinophilia is a haematological condition characterised by an increased absolute eosinophil count (AEC) in the peripheral blood, generally defined as greater than 0.5 × 10⁹/L (500 cells/µL).

Eosinophils are granulocytes involved in allergic reactions, defence against certain parasitic infections and immune-mediated inflammation.

The major causes of eosinophilia include allergic disorders, helminthic infections, skin diseases, connective tissue disorders and neoplasms.

Important Clinical Principle

Mild eosinophilia commonly occurs with allergic conditions, whereas persistent or marked eosinophilia requires evaluation for parasitic infections, drug reactions, systemic inflammatory diseases, haematological malignancies and eosinophil-mediated organ damage.

1. Classification of Eosinophilia

Severity Absolute Eosinophil Count
Mild 0.5–<1.5 × 10⁹/L
Moderate 1.5–5.0 × 10⁹/L
Severe Above 5.0 × 10⁹/L

Hypereosinophilia is generally defined as an AEC of at least 1.5 × 10⁹/L, particularly when persistent.

Hypereosinophilic syndrome refers to hypereosinophilia associated with eosinophil-mediated organ damage, after appropriate evaluation.

2. Pathophysiology

Eosinophilia results from increased production, activation or survival of eosinophils, often mediated by cytokines such as interleukin-5 (IL-5).

Immune Stimulation Allergy / Parasites Type 2 immune response Inflammation / Neoplasia IL-5 / Marrow Activation Eosinophilia

Eosinophils contain cytotoxic granule proteins, including major basic protein and eosinophil cationic protein.

Excessive eosinophil activation can damage tissues, particularly the heart, lungs, skin, gastrointestinal tract and nervous system.

3. Causes of Eosinophilia

A. Allergic Disorders

Allergic diseases are common causes of mild eosinophilia.

They are associated with type 2 immune responses involving IL-4, IL-5 and IL-13.

1. Asthma

Eosinophilia may occur in eosinophilic or allergic asthma.

Associated Findings

  • Episodic wheezing.
  • Breathlessness.
  • Chest tightness.
  • Cough, particularly at night or early morning.
  • Variable or reversible airflow obstruction.

Peripheral eosinophilia may support an eosinophilic asthma phenotype but is not diagnostic on its own.

2. Hay Fever (Allergic Rhinitis)

Hay fever is an IgE-associated allergic disorder affecting the nasal mucosa.

Typical Features

  • Sneezing.
  • Watery rhinorrhoea.
  • Nasal itching.
  • Nasal congestion.
  • Itchy or watery eyes.

Eosinophilia may accompany allergic rhinitis, although many patients have normal circulating eosinophil counts.

3. Drug Hypersensitivity

Drug hypersensitivity reactions may produce eosinophilia.

Important implicated medications include certain antibiotics, anticonvulsants and allopurinol.

Clinical manifestations range from mild rashes to severe systemic reactions.

Drug reaction with eosinophilia and systemic symptoms (DRESS) is an important potentially life-threatening condition characterised by a drug-associated eruption, fever and possible internal organ involvement.

Eosinophilia is common in DRESS but may be absent early.

Clinical Warning

Eosinophilia associated with a new medication, widespread rash, fever, facial swelling, lymphadenopathy or abnormal liver function should prompt urgent assessment for a severe drug hypersensitivity reaction.

B. Parasitic Infections – Helminths

Helminthic infections are important causes of eosinophilia, especially parasites with a tissue-invasive phase.

Eosinophils contribute to host defence against helminths through antibody-dependent mechanisms and release of cytotoxic granule proteins.

1. Ascariasis

Ascariasis is caused by Ascaris lumbricoides.

During larval migration through the lungs, patients may develop:

  • Cough.
  • Wheezing.
  • Transient pulmonary infiltrates.
  • Peripheral eosinophilia.

This pulmonary manifestation may be referred to as Löffler's syndrome.

Intestinal infection may cause abdominal discomfort, malnutrition or intestinal obstruction in heavy infections.

2. Schistosomiasis

Schistosomiasis is caused by Schistosoma species.

Eosinophilia is particularly associated with acute infection and early tissue migration.

Clinical Manifestations

  • Fever.
  • Abdominal pain.
  • Diarrhoea.
  • Hepatosplenomegaly.
  • Haematuria in urinary schistosomiasis.

Acute schistosomiasis may present as Katayama syndrome, with fever, systemic symptoms and marked eosinophilia.

Other Important Helminthic Causes

  • Strongyloidiasis.
  • Hookworm infection.
  • Filariasis.
  • Toxocariasis.
  • Trichinellosis.
Important Clinical Pearl

In patients with relevant epidemiological exposure, Strongyloides stercoralis infection should be considered before administering systemic corticosteroids because immunosuppression can precipitate life-threatening hyperinfection.

C. Skin Diseases

Certain inflammatory skin disorders are associated with eosinophilia.

1. Eczema (Atopic Dermatitis)

Atopic dermatitis is a chronic inflammatory skin disease associated with type 2 immune activation.

Typical Features

  • Pruritus.
  • Dry skin.
  • Erythematous eczematous lesions.
  • Lichenification in chronic disease.
  • Flexural involvement in many older children and adults.

Peripheral eosinophilia may be present, particularly in more severe atopic disease.

2. Dermatitis Herpetiformis

Dermatitis herpetiformis is an autoimmune blistering skin disorder strongly associated with gluten-sensitive enteropathy (coeliac disease).

Typical Findings

  • Intensely pruritic grouped papules and vesicles.
  • Lesions on extensor surfaces, including elbows, knees and buttocks.
  • Granular IgA deposition in dermal papillae on direct immunofluorescence.

Eosinophils may be present in skin lesions, but peripheral blood eosinophilia is not a defining or consistently present feature of dermatitis herpetiformis.

4. Connective Tissue and Inflammatory Disorders

A. Rheumatoid Arthritis (RA)

Rheumatoid arthritis is a chronic autoimmune inflammatory disorder affecting synovial joints.

Mild eosinophilia may occur, particularly in association with severe disease, extra-articular manifestations, coexisting atopy or medication reactions.

However, eosinophilia is not a characteristic diagnostic feature of uncomplicated rheumatoid arthritis.

B. Churg–Strauss Syndrome

Churg–Strauss syndrome, now termed eosinophilic granulomatosis with polyangiitis (EGPA), is a systemic eosinophilic inflammatory disease associated with small- to medium-vessel vasculitis.

It is strongly associated with asthma and eosinophilia.

Characteristic Features

  • Adult-onset asthma.
  • Chronic rhinosinusitis.
  • Nasal polyps.
  • Peripheral eosinophilia, sometimes marked.
  • Pulmonary infiltrates.
  • Peripheral neuropathy, including mononeuritis multiplex.
  • Purpura or other vasculitic skin lesions.
  • Possible cardiac involvement.

ANCA is present in only a subset of patients, commonly with an MPO-ANCA pattern.

Classic EGPA Clinical Pattern

Asthma + Eosinophilia + Systemic Vasculitis EGPA (Churg–Strauss)
Examination Pearl: Asthma with marked eosinophilia, sinus disease and mononeuritis multiplex strongly suggests EGPA.

C. Sarcoidosis

Sarcoidosis is a multisystem granulomatous inflammatory disease characterised by non-caseating granulomas.

Common Manifestations

  • Bilateral hilar lymphadenopathy.
  • Pulmonary infiltrates.
  • Erythema nodosum.
  • Uveitis.
  • Constitutional symptoms.

Mild peripheral eosinophilia may occur in some patients, but it is not a typical or defining feature.

Marked eosinophilia should prompt investigation for an alternative or additional cause.

5. Neoplasms

Eosinophilia may occur in association with malignancy through tumour-derived cytokines or clonal disorders affecting the eosinophil lineage.

A. Hodgkin Lymphoma

Hodgkin lymphoma may be associated with reactive eosinophilia due to cytokines produced within the tumour microenvironment.

Typical Clinical Features

  • Painless lymphadenopathy.
  • Fever.
  • Night sweats.
  • Unintentional weight loss.
  • Pruritus.

Peripheral eosinophilia is a recognised but nonspecific finding.

B. Non-Hodgkin Lymphoma

Certain non-Hodgkin lymphomas, particularly some T-cell lymphomas, may cause eosinophilia through cytokine-mediated mechanisms.

Clinical manifestations may include lymphadenopathy, constitutional symptoms and organ involvement.

C. Other Haematological Neoplasms

Persistent marked eosinophilia may also be associated with clonal myeloid neoplasms, including disorders with rearrangements involving PDGFRA, PDGFRB, FGFR1 or other tyrosine kinase genes.

These conditions are particularly important when eosinophilia is unexplained, persistent or accompanied by abnormal blood counts or organ involvement.

6. Clinical Features of Eosinophilia

Many patients with mild eosinophilia are asymptomatic.

Symptoms depend on the underlying disease and whether eosinophil-mediated organ damage is present.

Clinical Feature Possible Cause
Wheezing, breathlessnessAsthma, EGPA
Sneezing, rhinorrhoeaAllergic rhinitis
Pruritic rashAtopy, drug reaction, skin disease
Abdominal symptomsHelminthic infection
Fever and rash after medicationDrug hypersensitivity or DRESS
Pulmonary infiltratesHelminth migration, EGPA
Peripheral neuropathyEGPA
Lymphadenopathy and B symptomsLymphoma
Chest pain or heart failurePossible eosinophilic cardiac involvement

7. Investigations

A. Full Blood Count and Differential

Confirm the absolute eosinophil count rather than relying solely on the eosinophil percentage.

Absolute Eosinophil Count (AEC)

AEC = Total WBC × (% Eosinophils / 100)

B. Peripheral Blood Film

Assess eosinophil morphology and look for abnormal or immature cells that may suggest a haematological disorder.

C. History and Clinical Examination

Important Areas

  • Asthma, allergic rhinitis and eczema.
  • New medications and supplements.
  • Travel history and exposure to helminths.
  • Gastrointestinal or respiratory symptoms.
  • Skin rashes.
  • Lymphadenopathy.
  • Neurological symptoms.
  • Features of connective tissue disease.

D. Targeted Investigations

Investigation Clinical Indication
Stool examination for ova and parasitesSuspected intestinal helminth infection
Parasite serologySelected tissue-invasive helminths, including Strongyloides
Serum IgEMay support atopic or parasitic causes; nonspecific
Renal and liver functionAssess systemic involvement
ESR and CRPInflammatory disorders
ANCASuspected EGPA, recognising limited sensitivity
Chest imagingRespiratory symptoms or suspected pulmonary involvement
ECG, troponin, echocardiographySuspected cardiac involvement
Bone marrow and molecular testingPersistent unexplained or suspected clonal eosinophilia
Lymph node biopsySuspicious lymphadenopathy

A single negative stool examination does not reliably exclude all helminthic infections, particularly strongyloidiasis.

8. Diagnostic Approach

AEC >0.5 × 10⁹/L Confirm count and persistence Organ Damage or Severe Illness? Urgent assessment when present History and Examination Allergy, drugs, travel, parasites Skin, lungs, nodes, systemic signs Targeted Investigations Parasites, autoimmune, organ tests Clonal testing when indicated Cause-Specific Treatment Specialist review if unexplained

9. Management

Treatment is directed at the underlying cause.

Cause General Management
AsthmaInhaled corticosteroid-based treatment and phenotype-directed therapy
Allergic rhinitisIntranasal corticosteroids and antihistamines
Drug hypersensitivityDiscontinue the suspected drug and assess severity
AscariasisAppropriate anthelmintic treatment
SchistosomiasisPraziquantel according to infection stage and clinical guidance
EczemaEmollients and anti-inflammatory skin treatment
Dermatitis herpetiformisGluten-free diet; dapsone when appropriate
Rheumatoid arthritisDisease-modifying treatment of underlying RA
EGPASpecialist-directed glucocorticoids and immunosuppressive or biologic therapy
SarcoidosisObservation or immunosuppressive treatment depending on organ involvement
LymphomaDisease-specific oncological treatment
Clonal eosinophilic neoplasmMolecularly guided haematological treatment

Patients with hypereosinophilia and suspected cardiac, neurological or other organ involvement require prompt specialist assessment.

10. High-Yield Examination Summary

Cause Characteristic Association
AsthmaAllergic or eosinophilic airway inflammation
Hay feverAllergic rhinitis
Drug hypersensitivityRash, fever and possible systemic involvement
AscariasisLöffler's syndrome during pulmonary migration
SchistosomiasisAcute helminth infection; Katayama syndrome
EczemaAtopic dermatitis
Dermatitis herpetiformisCoeliac disease, granular IgA in skin
Rheumatoid arthritisOccasionally associated with mild eosinophilia
Churg–Strauss syndrome (EGPA)Asthma, eosinophilia and systemic vasculitis
SarcoidosisPossible mild eosinophilia; not a defining feature
Hodgkin lymphomaLymphadenopathy, B symptoms, possible eosinophilia
Other lymphomasCytokine-mediated eosinophilia, especially some T-cell lymphomas

11. Key Examination Pearls

  • Eosinophilia is generally defined as an AEC above 0.5 × 10⁹/L.
  • Allergic diseases commonly cause mild eosinophilia.
  • Helminths with tissue migration are particularly associated with eosinophilia.
  • Ascariasis may cause transient pulmonary infiltrates and eosinophilia, known as Löffler's syndrome.
  • Acute schistosomiasis may produce fever and marked eosinophilia.
  • Drug hypersensitivity may cause severe systemic illness, including DRESS.
  • Asthma with eosinophilia, sinus disease and neuropathy strongly suggests EGPA.
  • Eosinophilia may occur in Hodgkin lymphoma and some other lymphomas.
  • Persistent hypereosinophilia requires assessment for organ damage and possible clonal disease.
  • Strongyloidiasis must be considered before systemic corticosteroid treatment in patients with relevant exposure.
Most Important Examination Point

Eosinophilia with asthma and allergic rhinitis suggests atopy; eosinophilia with travel or helminth exposure suggests parasitic infection; eosinophilia with asthma, sinusitis and mononeuritis multiplex suggests EGPA; and eosinophilia with painless lymphadenopathy and B symptoms raises suspicion for lymphoma.

Clinical Warning

Persistent marked eosinophilia accompanied by chest pain, breathlessness, neurological abnormalities or other evidence of organ dysfunction requires urgent medical assessment. Eosinophil-mediated cardiac damage can be life-threatening.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments